RU2011102742A - METHOD FOR TREATING INVOLUTIONAL EYE DISEASES - Google Patents
METHOD FOR TREATING INVOLUTIONAL EYE DISEASES Download PDFInfo
- Publication number
- RU2011102742A RU2011102742A RU2011102742/14A RU2011102742A RU2011102742A RU 2011102742 A RU2011102742 A RU 2011102742A RU 2011102742/14 A RU2011102742/14 A RU 2011102742/14A RU 2011102742 A RU2011102742 A RU 2011102742A RU 2011102742 A RU2011102742 A RU 2011102742A
- Authority
- RU
- Russia
- Prior art keywords
- treatment
- optical
- treatment method
- reflex training
- carried out
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Способ лечения инволюционных заболеваний глаз, включающий субконъюнктивальные или парабульбарные инъекции биогенных пептидов, антиоксидантов, отличающийся тем, что за 5-60 мин до инъекции проводят сеанс оптико-рефлекторной тренировки со сферическими и сферопризматическими линзами цилиарной и глазодвигательных мышц в течение 10-20 мин. ! 2. Способ лечения по п.1, отличающийся тем, что оптико-рефлекторную тренировку проводят на аппарате «Визотроник». ! 3. Способ лечения по п.1, отличающийся тем, что в качестве лекарственных препаратов вводят ретиналамин и гистохром. ! 4.Способ лечения по п.1, отличающийся тем, что оптико-рефлекторную тренировку и последующее введение лекарственных препаратов проводят в течение 10-15-дневного курса лечения. 1. A method for the treatment of involutional diseases of the eye, including subconjunctival or parabulbar injections of biogenic peptides, antioxidants, characterized in that 5-60 minutes before the injection they conduct a session of optical reflex training with spherical and sphere-prismatic lenses of the ciliary and oculomotor muscles for 10-20 minutes . ! 2. The treatment method according to claim 1, characterized in that the optical-reflex training is carried out on the apparatus "Visotronic". ! 3. The treatment method according to claim 1, characterized in that retinalamine and histochrome are administered as medicaments. ! 4. The treatment method according to claim 1, characterized in that the optical reflex training and subsequent administration of drugs are carried out during a 10-15-day course of treatment.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2011102742/14A RU2565840C2 (en) | 2011-01-25 | 2011-01-25 | Method of treating involutional eye diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2011102742/14A RU2565840C2 (en) | 2011-01-25 | 2011-01-25 | Method of treating involutional eye diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2011102742A true RU2011102742A (en) | 2012-07-27 |
RU2565840C2 RU2565840C2 (en) | 2015-10-20 |
Family
ID=46850434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011102742/14A RU2565840C2 (en) | 2011-01-25 | 2011-01-25 | Method of treating involutional eye diseases |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2565840C2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2622759C1 (en) * | 2016-06-08 | 2017-06-19 | федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) | Method for macular area morphometric changes treatment in case of polymorbide somatic conditions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2206299C2 (en) * | 2001-07-04 | 2003-06-20 | Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" | Method for treating optic nerve diseases |
RU2442551C2 (en) * | 2010-01-28 | 2012-02-20 | Общество с ограниченной ответственностью "Добродар" | The means of precaution and healing of myopia |
-
2011
- 2011-01-25 RU RU2011102742/14A patent/RU2565840C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2565840C2 (en) | 2015-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA3132731A1 (en) | Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations | |
EA201590902A1 (en) | METHODS AND DEVICES APPLICABLE FOR THE TREATMENT OF EYE DISEASES IN HUMAN | |
EA201491711A1 (en) | CONJUGATES OF NONLINEAR MULTIPLACE COPOLYMER WITH A MEDICINE FOR DELIVERY OF ACTIVE AGENTS | |
SG191334A1 (en) | Use of a vegf antagonist to treat angiogenic eye disorders | |
RU2016104398A (en) | USE OF VEGF ANTAGONIST FOR TREATMENT OF RETROLENTAL FIBROPLASIA | |
EA201791337A1 (en) | COMPOSITIONS OF SUITINIBA AND METHODS OF THEIR APPLICATION IN THE TREATMENT OF EYE DISTURBANCES | |
JP2012532859A5 (en) | ||
MX2020005217A (en) | Ophthalmic composition and delivery device thereof. | |
RU2014150942A (en) | TREATMENT OF SIDE EFFECTS IN THE FORM OF MOTOR AND MOTOR DISORDERS RELATED TO THE TREATMENT OF PARKINSON'S DISEASE | |
EP4324454A3 (en) | Cross-linking agents and associated methods | |
EA201400002A1 (en) | METHODS TO TREAT DISEASES OF THE RETAIL | |
RU2013123646A (en) | COMBINED COMPOSITION | |
RU2014103543A (en) | Botulinum toxins for use in the treatment of fatty deposits | |
JOP20200031A1 (en) | Methods of treatment of osteoarthritis with transdermal cannabidiol gel | |
RU2010138239A (en) | METHOD FOR TREATING DISEASES OF THE VISUAL NERVE AND RETAIL | |
WO2014161004A3 (en) | Compositions and methods for the delivery of drugs to the ocular surface by contact lenses | |
RU2015112121A (en) | MI-RNA AND THEIR APPLICATION IN METHODS AND COMPOSITIONS FOR TREATMENT AND / OR PREVENTION OF EYE CONDITIONS | |
RU2011102742A (en) | METHOD FOR TREATING INVOLUTIONAL EYE DISEASES | |
RU2013104381A (en) | TREATMENT OF VASCULARIZED PIGMENT EPITELIUM EXTREMITATION THERAPY AGAINST VEGF | |
AU2020231505A8 (en) | Sequential intravitreal administration of AAV gene therapy to contralateral eyes | |
Kuhad et al. | Neuroprotective effect of sesamol and quercetin against QA induced neurotoxicity: An experimental paradigm of Huntington's disease | |
MD612Y (en) | Device and method for treatment of senile cataract | |
EA201690903A1 (en) | TREATMENT GLAUCOMA USING LAQUINIMODE | |
RU2011133463A (en) | METHOD FOR TREATING EXTREMES OF CHRONIC LARINGITIS | |
RU2014106328A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 4-BROM-N- (IMIDAZOLIDIN-2-YLIDENE) -1H-BENZIMIDAZOL-5-AMINE FOR THE TREATMENT OF RETAIL DISEASES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HZ9A | Changing address for correspondence with an applicant | ||
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20160126 |